Cost-Utility Analysis of Carotid Artery Angioplasty and Carotid Endarterectomy in Iran

  • Mohammad Taghi Ashoobi Guilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran.
  • Sara Zahedfar Razi Clinical Research Development Center, Guilan University of Medical Sciences, Rasht, Iran.
  • Hossein Hemmati Guilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran.
  • Enayatollah Homaie Rad Social Determinants of Health Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran.
Keywords: Cost Utility; Economics Evaluation; Carotid Artery Angioplasty; Carotid Endarterectomy

Abstract

Background: Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are two standard methods for the prevention and treatment of cerebrovascular accidents.

Objectives: This study compared these two methods using an economic evaluation analysis.

Methods: One hundred patients with carotid occlusive disease at Razi Hospital in Rasht, Iran, were analyzed in a retrospective cost-utility study using the SF-12 Questionnaire to calculate quality-adjusted life year (QALY) and costs from a societal perspective. This study employed Monte Carlo simulation and sensitivity analysis for data analysis.

Results: Of the 100 patients, 61 were male, and 64 underwent CEA treatment. The incremental cost-effectiveness ratio (ICER) of CAS versus CEA was US$ 213.6 (± 111.2). The ICER increased to US$ 1625.6 when governmental currency exchange subsidies were excluded from the cost calculations of the two methods.

Conclusions: Both the costs and QALY of CAS are higher than those of CEA. The CAS is cost-effective when the preferred currency rate is applied to medical equipment pricing [compared to the willingness to pay (WTP) threshold of US$ 1431.85]. However, it is not cost-effective when government subsidies are removed.

Published
2025-05-21
Section
Articles